摘要 |
<p>The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, including all stereoisomers and tautomers, which is an inhibitor of p38 mitogen-activated protein kinase enzymes(referred to herein as p38 MAP kinase inhibitors), particularly the alpha and gamma kinase sub-types thereof, and itsuse in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD.</p> |
申请人 |
RESPIVERT LIMITED |
发明人 |
ITO, KAZUHIRO;STRONG, PETER;RAPEPORT, WILLIAM GARTH;MURRAY, PETER JOHN;KING-UNDERWOOD, JOHN;WILLIAMS, JONATHAN GARETH;ONIONS, STUART;CHARRON, CATHERINE ELISABETH |